OKYO Pharma Ltd SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KOKYO Pharma LtdOKYOOct 6

   OKYO Pharma announces Phase 3 trial start

   • Phase 3 NEPTUNE trial initiated on 2026-10-06
   • First patients enrolled at Toyos Clinic in Nashville, TN
   • Urcosimod is tested for neuropathic corneal pain
2. ROUTINE6-KOKYO Pharma LtdOKYOSep 29

   Foreign issuer report

3. ROUTINE6-KOKYO Pharma LtdOKYOSep 9

   Foreign issuer report

4. ROUTINE6-KOKYO Pharma LtdOKYOSep 8

   Foreign issuer report

5. ROUTINE20-F/AOKYO Pharma LtdOKYOAug 7

   Annual report (amended)

6. ROUTINE4/AOKYO Pharma LtdOKYOAug 7

   7 insider filings

   Robert John Dempsey, insider filing for OKYO (amended)

   Show all 7

   • 4/AInsider filing for OKYO (amended)Aug 7
   • 4/AInsider filing for OKYO (amended)Aug 7
   • 4/AInsider filing for OKYO (amended)Aug 7
   • 4/AInsider filing for OKYO (amended)Aug 7
   • 4/AInsider filing for OKYO (amended)Aug 7
   • 4/AInsider filing for OKYO (amended)Aug 7
   • 4/AInsider filing for OKYO (amended)Aug 7

   Robert John Dempsey, reporting

7. ROUTINE4OKYO Pharma LtdOKYOJul 29

   2 insider filings

   Rajkumar V. Patil, insider filing for OKYO

   Show all 2

   • 4Insider filing for OKYOJul 29
   • 3New insider at OKYOJul 29

   Rajkumar Patil V., reporting

8. ROUTINE6-KOKYO Pharma LtdOKYOJul 28

   Foreign issuer report

9. ROUTINE6-KOKYO Pharma LtdOKYOJul 27

   Foreign issuer report

10. ROUTINE4OKYO Pharma LtdOKYOJul 23

    4 insider filings

    Robert John Dempsey, insider filing for OKYO

    Show all 4

    • 4Insider filing for OKYOJul 23
    • 4Insider filing for OKYOJul 23
    • 4Insider filing for OKYOJul 23
    • 4Insider filing for OKYOJul 23

    Robert John Dempsey, reporting

11. ROUTINE6-KOKYO Pharma LtdOKYOJul 23

    Foreign issuer report

12. ROUTINE6-KOKYO Pharma LtdOKYOJul 23

    Foreign issuer report

13. ROUTINE4OKYO Pharma LtdOKYOJul 22

    Flavio Mantelli, insider filing for OKYO

    Flavio Mantelli, reporting

14. ROUTINE6-KOKYO Pharma LtdOKYOJul 22

    Foreign issuer report

15. ROUTINE6-KOKYO Pharma LtdOKYOJul 22

    Foreign issuer report

16. ROUTINE6-KOKYO Pharma LtdOKYOJul 22

    Foreign issuer report

17. ROUTINE4OKYO Pharma LtdOKYOJul 21

    Gabriele M Cerrone, insider filing for OKYO

    Gabriele M Cerrone, reporting

18. ROUTINE6-KOKYO Pharma LtdOKYOJul 21

    Foreign issuer report

19. ROUTINE6-KOKYO Pharma LtdOKYOJul 21

    Foreign issuer report

20. ROUTINE6-KOKYO Pharma LtdOKYOJul 20

    Foreign issuer report

21. NOTABLE20-FOKYO Pharma LtdOKYOJul 20

    Annual report

22. ROUTINE6-KOKYO Pharma LtdOKYOJul 8

    Foreign issuer report

23. ROUTINE6-KOKYO Pharma LtdOKYOJul 7

    Foreign issuer report

24. ROUTINE3OKYO Pharma LtdOKYOJun 17

    Flavio Mantelli, new insider at OKYO

    Flavio Mantelli, reporting

25. ROUTINE4OKYO Pharma LtdOKYOJun 10

    5 insider filings

    Keeren Rameshchandra Shah, insider filing for OKYO

    Show all 5

    • 4Insider filing for OKYOJun 10
    • 4Insider filing for OKYOJun 10
    • 4Insider filing for OKYOJun 10
    • 4Insider filing for OKYOJun 10
    • 4Insider filing for OKYOJun 10

    Keeren Rameshchandra Shah, reporting

26. ROUTINE3OKYO Pharma LtdOKYOJun 2

    Bernard Denoyer, new insider at OKYO

    Bernard Denoyer, reporting

27. ROUTINE3OKYO Pharma LtdOKYOJun 1

    2 insider filings

    Willy Jules Simon, new insider at OKYO

    Show all 2

    • 3New insider at OKYOJun 1
    • 3New insider at OKYOJun 1

    Willy Jules Simon, reporting

28. ROUTINE3OKYO Pharma LtdOKYOMay 22

    2 insider filings

    Robert John Dempsey, new insider at OKYO

    Show all 2

    • 3New insider at OKYOMay 22
    • 3New insider at OKYOMay 22

    Robert John Dempsey, reporting

29. ROUTINE6-KOKYO Pharma LtdOKYOMay 19

    Foreign issuer report

30. ROUTINESCHEDULE 13G/AOKYO Pharma LtdOKYOMay 15

    Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

    Point72 Asset Management, L.P., filed by

31. ROUTINESCHEDULE 13GOKYO Pharma LtdOKYOMay 15

    2 13G filings

    Ownership stake disclosure by Woodline Partners LP

    Show all 2

    • SCHEDULE 13GOwnership stake disclosureMay 15
    • SCHEDULE 13GOwnership stake disclosureMay 15

    Woodline Partners LP, filed by

32. ROUTINE6-KOKYO Pharma LtdOKYOApr 29

    Foreign issuer report

33. ROUTINE6-KOKYO Pharma LtdOKYOApr 7

    Foreign issuer report

Older filings on EDGAR